BeiGene Ltd ADR buy Royal Bank of Canada
Start price
12.09.23
/
50%
€191.00
Target price
12.09.24
€241.54
Performance (%)
-6.28%
End price
13.09.24
€179.00
Summary
This prediction ended on 13.09.24 with a price of €179.00. With a performance of -6.28%, the BUY prediction for BeiGene Ltd ADR by Royal_Bank_of_Canada closed slightly in the red. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | 4.545% | 4.545% | 35.294% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $259.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten